We found that BRAF mutant colon cancer had higher stromal score (p = 0.02), immune score (p < 0.0001), ESTIMATE score (p = 0.0001), and lower tumor purity (p = 0.0003) (Figure 1A). This evidence concerns the gene BRAF and malignant colon neoplasm.